Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma

Journal of Investigative Dermatology(2021)10.1016/j.jid.2020.12.035Source: DataRank Database

The Molecular Context of Vulnerability for CDK9 Suppression in Triple Wild-Type Melanoma is a research paper published in Journal of Investigative Dermatology (2021). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: bronzeTopics (35)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Michael F. Shaughnessy ORCID,Anpuchchelvi Rajadurai ORCID,Michael Taylor ORCID,Raj Kumar ORCID,Zhenyu Ji ORCID

Live enrichment

PubMed:33745909 PMC:PMC8316294

National Institutes of Health

Grant: K24-CA149202

NCI NIH HHS

Grant: K24 CA149202

National Institutes of Health

Grant: 5K24CA149202-05

Molecular Risk Assessment in Hereditary Melanoma

Melanoma Research Alliance

American Skin Association

bronzeLicense: Elsevier Non-Commercial

publisherhttp://www.jidonline.org/article/S0022202X21009775/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21009775?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022202X21009775?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8316294

https://doi.org/10.1016/j.jid.2020.12.035

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

Cell Line, TumorHumansMelanomaSkin NeoplasmsOxazolesThiazolesGTP PhosphohydrolasesProto-Oncogene Proteins B-rafNeurofibromin 1Membrane ProteinsProtein Kinase InhibitorsDrug Screening Assays, AntitumorTranscription, GeneticGene Expression Regulation, NeoplasticMutationCyclin-Dependent Kinase 9

Keywords

Proto-Oncogene Proteins B-rafNeurofibromin 1Skin NeoplasmsTranscription, GeneticMembrane ProteinsCyclin-Dependent Kinase 9GTP PhosphohydrolasesGene Expression Regulation, NeoplasticThiazolesCell Line, TumorMutationHumansDrug Screening Assays, AntitumorMelanomaOxazolesProtein Kinase Inhibitors